SWP
PDSB icon

Stratos Wealth Partners’s PDS Biotechnology PDSB Stock Holding History

Stratos Wealth Partners’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,303
Closed -$11.4K – 1640
2025
Q3 		$11.4K Hold
11,303
– – ﹤0.01% 1545
2025
Q2 		$15K Buy
+11,303
New +$15.3K ﹤0.01% 1414

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stratos Wealth Partners's PDSB Position: Q4 2025 in Review

Stratos Wealth Partners sold out of PDS Biotechnology (PDSB) in Q4 2025, closing a stake of 11,303 shares — an estimated $11.4K sold.

Stratos Wealth Partners first reported a position in PDSB in Q2 2025 and held it in 2 quarters. The position peaked at $15K in Q2 2025. 44 funds tracked by Wall St. Rank hold PDSB as of Q4 2025.

  • Stratos Wealth Partners reported no remaining PDS Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Stratos Wealth Partners sold 11,303 PDS Biotechnology shares in Q4 2025, an estimated $11.4K.
  • Stratos Wealth Partners first reported a position in PDS Biotechnology in Q2 2025 and held it in 2 quarters.
  • Stratos Wealth Partners's PDS Biotechnology position peaked at $15K in Q2 2025.
  • 44 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2025.

Based on Stratos Wealth Partners's 13F filing for Q4 2025, filed 20 Jan 2026.